Stability of p53 Homologs

PLoS ONE

Volumn 7, Issue 10, 2012, Pages

  Brandt, Tobias ^a,b,c   Kaar, Joel L ^a,d   Fersht, Alan R ^a,b   Veprintsev, Dmitry B ^a,b,e  

^a MRC CENTRE FOR PROTEIN ENGINEERING   (United Kingdom)

^b MRC LABORATORY OF MOLECULAR BIOLOGY   (United Kingdom)

^c MAX PLANCK INSTITUTE OF BIOPHYSICS   (Germany)

^d UCB 450   (United States)

^e PAUL SCHERRER INSTITUTE   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P53; PROTEIN P73;

ARTICLE; BODY TEMPERATURE; CHEMICAL REACTION KINETICS; DNA BINDING; DROSOPHILA MELANOGASTER; FLUOROMETRY; GENE; GENETIC STABILITY; HALF LIFE TIME; HUMAN; MOUSE; NONHUMAN; ORTHOLOGY; P53 GENE; P73 GENE; PARALOGY; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN STABILITY; REAL TIME POLYMERASE CHAIN REACTION; SEQUENCE HOMOLOGY; TEMPERATURE SENSITIVITY; THERMOSTABILITY; XENOPUS LAEVIS; ZEBRA FISH;

ANIMALS; BINDING SITES; DNA-BINDING PROTEINS; DROSOPHILA; HUMANS; KINETICS; MICE; NUCLEAR PROTEINS; PROTEIN DENATURATION; PROTEIN STABILITY; PROTEIN STRUCTURE, TERTIARY; THERMODYNAMICS; TRANSCRIPTION FACTORS; TUMOR SUPPRESSOR PROTEIN P53; TUMOR SUPPRESSOR PROTEINS; XENOPUS; ZEBRAFISH;

EID: 84868132814     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0047889     Document Type: Article

References (45)

1. DePristo MA, Weinreich DM, Hartl DL, (2005) Missense meanderings in sequence space: a biophysical view of protein evolution. Nat Rev Genet 6: 678-687.
2. Somero GN, (2004) Adaptation of enzymes to temperature: searching for basic "strategies". Comp Biochem Physiol B Biochem Mol Biol 139: 321-333.
3. Tokuriki N, Tawfik DS, (2009) Stability effects of mutations and protein evolvability. Curr Opin Struct Biol 19: 596-604.
4. Serrano L, Day AG, Fersht AR, (1993) Step-wise mutation of barnase to binase. A procedure for engineering increased stability of proteins and an experimental analysis of the evolution of protein stability. J Mol Biol 233: 305-312.
5. Somero GN, (1995) Proteins and temperature. Annu Rev Physiol 57: 43-68.
6. Yang A, Schweitzer R, Sun D, Kaghad M, Walker N, et al. (1999) p63 is essential for regenerative proliferation in limb, craniofacial and epithelial development. Nature 398: 714-718.
7. Yang A, Walker N, Bronson R, Kaghad M, Oosterwegel M, et al. (2000) p73-deficient mice have neurological, pheromonal and inflammatory defects but lack spontaneous tumours. Nature 404: 99-103.
8. Ang HC, Joerger AC, Mayer S, Fersht AR, (2006) Effects of common cancer mutations on stability and DNA binding of full-length p53 compared with isolated core domains. J Biol Chem 281: 21934-21941.
9. Bullock AN, Fersht AR, (2001) Rescuing the function of mutant p53. Nat Rev Cancer 1: 68-76.
10. Bullock AN, Henckel J, DeDecker BS, Johnson CM, Nikolova PV, et al. (1997) Thermodynamic stability of wild-type and mutant p53 core domain. Proc Natl Acad Sci U S A 94: 14338-14342.
11. Bullock AN, Henckel J, Fersht AR, (2000) Quantitative analysis of residual folding and DNA binding in mutant p53 core domain: definition of mutant states for rescue in cancer therapy. Oncogene 19: 1245-1256.
12. Joerger AC, Fersht AR, (2010) The tumor suppressor p53: from structures to drug discovery. Cold Spring Harb Perspect Biol 2: a000919.
13. Vogelstein B, Lane D, Levine AJ, (2000) Surfing the p53 network. Nature 408: 307-310.
14. Vousden KH, Lu X, (2002) Live or let die: the cell's response to p53. Nat Rev Cancer 2: 594-604.
15. Khoo KH, Andreeva A, Fersht AR, (2009) Adaptive evolution of p53 thermodynamic stability. J Mol Biol 393: 161-175.
16. Klein C, Georges G, Kunkele KP, Huber R, Engh RA, et al. (2001) High thermostability and lack of cooperative DNA binding distinguish the p63 core domain from the homologous tumor suppressor p53. J Biol Chem 276: 37390-37401.
17. Patel S, Bui TT, Drake AF, Fraternali F, Nikolova PV, (2008) The p73 DNA binding domain displays enhanced stability relative to its homologue, the tumor suppressor p53, and exhibits cooperative DNA binding. Biochemistry 47: 3235-3244.
18. Friedler A, Veprintsev DB, Hansson LO, Fersht AR, (2003) Kinetic instability of p53 core domain mutants: implications for rescue by small molecules. J Biol Chem 278: 24108-24112.
19. Brachmann RK, Yu K, Eby Y, Pavletich NP, Boeke JD, (1998) Genetic selection of intragenic suppressor mutations that reverse the effect of common p53 cancer mutations. EMBO J 17: 1847-1859.
20. Matsumura I, Ellington AD, (1999) In vitro evolution of thermostable p53 variants. Protein Sci 8: 731-740.
21. Nikolova PV, Henckel J, Lane DP, Fersht AR, (1998) Semirational design of active tumor suppressor p53 DNA binding domain with enhanced stability. Proc Natl Acad Sci U S A 95: 14675-14680.
22. Natan E, Baloglu C, Pagel K, Freund SM, Morgner N, et al. (2011) Interaction of the p53 DNA-Binding Domain with Its N-Terminal Extension Modulates the Stability of the p53 Tetramer. J Mol Biol 409: 358-368.
23. Pantoliano MW, Petrella EC, Kwasnoski JD, Lobanov VS, Myslik J, et al. (2001) High-density miniaturized thermal shift assays as a general strategy for drug discovery. J Biomol Screen 6: 429-440.
24. Vedadi M, Niesen FH, Allali-Hassani A, Fedorov OY, Finerty PJ Jr, et al. (2006) Chemical screening methods to identify ligands that promote protein stability, protein crystallization, and structure determination. Proc Natl Acad Sci U S A 103: 15835-15840.
25. Epps DE, Sarver RW, Rogers JM, Herberg JT, Tomich PK, (2001) The ligand affinity of proteins measured by isothermal denaturation kinetics. Anal Biochem 292: 40-50.
26. Sarver RW, Rogers JM, Epps DE, (2002) Determination of ligand-MurB interactions by isothermal denaturation: application as a secondary assay to complement high throughput screening. J Biomol Screen 7: 21-28.
27. Senisterra GA, Soo Hong B, Park HW, Vedadi M, (2008) Application of high-throughput isothermal denaturation to assess protein stability and screen for ligands. J Biomol Screen 13: 337-342.
28. Wang G, Fersht AR, (2012) First-order rate-determining aggregation mechanism of p53 and its implications. Proc Natl Acad Sci U S A 109: 13590-13595.
29. Wilcken R, Wang G, Boeckler FM, Fersht AR, (2012) Kinetic mechanism of p53 oncogenic mutant aggregation and its inhibition. Proc Natl Acad Sci U S A 109: 13584-13589.
30. Brandt T, Petrovich M, Joerger AC, Veprintsev DB, (2009) Conservation of DNA-binding specificity and oligomerisation properties within the p53 family. BMC Genomics 10: 628.
31. Ano Bom AP, Rangel LP, Costa DC, de Oliveira GA, Sanches D, et al. (2012) Mutant p53 Aggregates into Prion-like Amyloid Oligomers and Fibrils: IMPLICATIONS FOR CANCER. J Biol Chem 287: 28152-28162.
32. Ishimaru D, Andrade LR, Teixeira LS, Quesado PA, Maiolino LM, et al. (2003) Fibrillar aggregates of the tumor suppressor p53 core domain. Biochemistry 42: 9022-9027.
33. Boeckler FM, Joerger AC, Jaggi G, Rutherford TJ, Veprintsev DB, et al. (2008) Targeted rescue of a destabilized mutant of p53 by an in silico screened drug. Proc Natl Acad Sci U S A 105: 10360-10365.
34. Ishimaru D, Ano Bom AP, Lima LM, Quesado PA, Oyama MF, et al. (2009) Cognate DNA stabilizes the tumor suppressor p53 and prevents misfolding and aggregation. Biochemistry 48: 6126-6135.
35. Veprintsev DB, Fersht AR, (2008) Algorithm for prediction of tumour suppressor p53 affinity for binding sites in DNA. Nucleic Acids Res 36: 1589-1598.
36. Joerger AC, Fersht AR, (2008) Structural biology of the tumor suppressor p53. Annu Rev Biochem 77: 557-582.
37. Dotsch V, Bernassola F, Coutandin D, Candi E, Melino G, (2010) p63 and p73, the ancestors of p53. Cold Spring Harbor perspectives in biology 2: a004887.
38. Moll UM, Slade N, (2004) p63 and p73: roles in development and tumor formation. Mol Cancer Res 2: 371-386.
39. Joerger AC, Allen MD, Fersht AR, (2004) Crystal structure of a superstable mutant of human p53 core domain. Insights into the mechanism of rescuing oncogenic mutations. J Biol Chem 279: 1291-1296.
40. Hipps DS, Packman LC, Allen MD, Fuller C, Sakaguchi K, et al. (1994) The peripheral subunit-binding domain of the dihydrolipoyl acetyltransferase component of the pyruvate dehydrogenase complex of Bacillus stearothermophilus: preparation and characterization of its binding to the dihydrolipoyl dehydrogenase component. Biochem J 297 (Pt 1): 137-143.
41. Joerger AC, Ang HC, Fersht AR, (2006) Structural basis for understanding oncogenic p53 mutations and designing rescue drugs. Proc Natl Acad Sci U S A 103: 15056-15061.
42. Veprintsev DB, Freund SM, Andreeva A, Rutledge SE, Tidow H, et al. (2006) Core domain interactions in full-length p53 in solution. Proc Natl Acad Sci U S A 103: 2115-2119.
43. Ashburner M, Thompson JN Jr (1978) The Laboratory culture of Drosophila. In: Ashburner M, Wright TRF, editors. The Genetics and Biology of Drosophila. London: Academic Press.
44. Matthews M, Trevarrow B, Matthews J, (2002) A virtual tour of the Guide for zebrafish users. Lab Anim (NY) 31: 34-40.
45. Hilken G, Dimigen J, Iglauer F, (1995) Growth of Xenopus laevis under different laboratory rearing conditions. Lab Anim 29: 152-162.